Are AI chatbots concordant with evidence-based cancer screening recommendations?
Authors:
Open Access
- 21 January 2025
- journal article
- Published by Elsevier in Patient Education and Counseling
- Vol. 134, 108677
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (2016719)
- National Health and Medical Research Council (2017278)
- National Health and Medical Research Council (1194410)
- National Health and Medical Research Council (1194108)
- Prostate Cancer Foundation of Australia
- National Breast Cancer Foundation (2023/IIRS0028)
- National Breast Cancer Foundation (EC-21-001)
This publication has 16 references indexed in Scilit:
- FTC Regulation of AI-Generated Medical DisinformationJAMA, 2024
- Screening for Breast CancerJAMA, 2024
- Health benefits and harms of mammography screening in older women (75+ years)—a systematic reviewBritish Journal of Cancer, 2023
- New Frontiers in Health Literacy: Using ChatGPT to Simplify Health Information for People in the CommunityJournal of General Internal Medicine, 2023
- Assessment of Artificial Intelligence Chatbot Responses to Top Searched Queries About CancerJAMA Oncology, 2023
- Use of Artificial Intelligence Chatbots for Cancer Treatment InformationJAMA Oncology, 2023
- Can ChatGPT, an Artificial Intelligence Language Model, Provide Accurate and High-quality Patient Information on Prostate Cancer?Urology, 2023
- Screening for Prostate CancerJAMA, 2018
- Prostate-Specific Antigen (PSA) Screening for Prostate CancerJAMA, 2018
- Patients’ use of the internet for medical informationJournal of General Internal Medicine, 2002